- Home
- NVGS vs PRCT Comparison
NVGS vs PRCT Comparison
Compare NVGS & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVGS | PRCT |
|---|---|---|
| Founded | 1997 | 2009 |
| Country | United Kingdom | United States |
| Employees | N/A | 888 |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NVGS | PRCT |
|---|---|---|
| Price | $23.07 | $20.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $21.50 | ★ $35.44 |
| AVG Volume (30 Days) | 332.7K | ★ 930.8K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.30% | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $308,054,000.00 |
| Revenue This Year | N/A | $31.34 |
| Revenue Next Year | N/A | $24.52 |
| P/E Ratio | $13.06 | ★ N/A |
| Revenue Growth | N/A | ★ 37.22 |
| 52 Week Low | $14.08 | $16.67 |
| 52 Week High | $24.36 | $40.10 |
Technical Indicators
Market Signals| Indicator | NVGS | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 60.78 | 45.20 |
| Support Level | $21.41 | $19.87 |
| Resistance Level | $23.16 | $29.27 |
| Average True Range (ATR) | 0.55 | 1.04 |
| MACD | 0.07 | -0.12 |
| Stochastic Oscillator | 72.46 | 10.08 |
Price Performance
Historical ComparisonAbout NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). The company plays a vital role in the globalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users, and commodity traders.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.